These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 39239)

  • 1. Quantitative resolution of beta-adrenergic receptor subtypes by selective ligand binding: application of a computerized model fitting technique.
    Hancock AA; DeLean AL; Lefkowitz RJ
    Mol Pharmacol; 1979 Jul; 16(1):1-9. PubMed ID: 39239
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective alteration in high affinity agonist binding: a mechanism of beta-adrenergic receptor desensitization.
    Wessels MR; Mullikin D; Lefkowitz RJ
    Mol Pharmacol; 1979 Jul; 16(1):10-20. PubMed ID: 39240
    [No Abstract]   [Full Text] [Related]  

  • 3. A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data.
    Kent RS; De Lean A; Lefkowitz RJ
    Mol Pharmacol; 1980 Jan; 17(1):14-23. PubMed ID: 6104284
    [No Abstract]   [Full Text] [Related]  

  • 4. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes.
    Minneman KP; Hegstrand LR; Molinoff PB
    Mol Pharmacol; 1979 Jul; 16(1):34-46. PubMed ID: 39246
    [No Abstract]   [Full Text] [Related]  

  • 5. Affinity chromatography of the beta-adrenergic receptor and characterization of antibodies raised against purified receptor preparations.
    Caron MG; Srinivasan Y; Lefkowitz RJ
    Adv Biochem Psychopharmacol; 1980; 21():151-8. PubMed ID: 6103643
    [No Abstract]   [Full Text] [Related]  

  • 6. Coexistence of beta1 and beta2 adrenoceptors in mammalian lung: evidence from direct binding studies.
    Rugg EL; Barnett DB; Nahorski SR
    Mol Pharmacol; 1978 Nov; 14(6):996-1005. PubMed ID: 32480
    [No Abstract]   [Full Text] [Related]  

  • 7. Identity of [3H]dihydroalprenolol binding sites and beta-2 adrenergic receptors coupled with adenylate cyclase in guinea-pig skeletal muscle sarcolemma: general properties and structure-activity relationships.
    Wei JW; Sulakhe PV
    J Pharmacol Exp Ther; 1980 Jul; 214(1):186-96. PubMed ID: 6104715
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of beta adrenoceptor antagonist affinity and cardioselectivity by radioligand-receptor assay.
    Gibson RE; Rzeszotarski WJ; Komai T; Reba RC; Eckelman WC
    J Pharmacol Exp Ther; 1979 Apr; 209(1):153-61. PubMed ID: 34714
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of pH changes on the binding of agonists and antagonists to the adrenergic beta receptor].
    Gende OA; Camilión de Hurtado MC; Cingolani HE
    Acta Physiol Pharmacol Latinoam; 1985; 35(2):205-16. PubMed ID: 2870603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta1- and beta2-adrenergic receptors responsible for cyclic AMP accumulation in isolated heart and lung cells.
    Hazeki O; Ui M
    Mol Pharmacol; 1980 Jan; 17(1):8-13. PubMed ID: 6104287
    [No Abstract]   [Full Text] [Related]  

  • 11. Antagonist dissociation constants and relative agonist efficacies for compounds interacting with beta-1 and beta-2 adrenergic receptors in the rat jugular vein.
    Cohen ML; Ruffolo RR; Wiley KS
    J Pharmacol Exp Ther; 1980 Nov; 215(2):325-31. PubMed ID: 6108357
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of specificity of agonist and antagonist radioligand binding to beta adrenergic receptors.
    Lefkowitz RJ; Hamp M
    Nature; 1977 Aug; 268(5619):453-4. PubMed ID: 19707
    [No Abstract]   [Full Text] [Related]  

  • 13. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.
    De Lean A; Hancock AA; Lefkowitz RJ
    Mol Pharmacol; 1982 Jan; 21(1):5-16. PubMed ID: 6982395
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenergic ligand liposolubility in membranes. Direct assessment in a beta-adrenergic binding system.
    Dax EM; Partilla JS
    Mol Pharmacol; 1982 Jul; 22(1):5-7. PubMed ID: 6289075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac beta2-adrenoceptor in the frog.
    Stene-Larsen G; Helle KB
    Comp Biochem Physiol C Comp Pharmacol; 1978; 60(2):165-73. PubMed ID: 28888
    [No Abstract]   [Full Text] [Related]  

  • 16. Agonist- induced transconformation of beta-adrenergic receptors, and adenylate cyclase activation [proceedings].
    Vauquelin G; Bottari S; Strosberg AD
    Arch Int Physiol Biochim; 1979 Oct; 87(4):859-60. PubMed ID: 93949
    [No Abstract]   [Full Text] [Related]  

  • 17. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors.
    Weiland GA; Minneman KP; Molinoff PB
    Mol Pharmacol; 1980 Nov; 18(3):341-7. PubMed ID: 6110167
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of beta-adrenergic receptors in rat ovary.
    Laszlovszky I; Erdö SL
    Eur J Pharmacol; 1983 Dec; 96(1-2):101-4. PubMed ID: 6141056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta adrenergic receptors of rat corpus luteum membranes.
    Coleman AJ; Paterson DS; Somerville AR
    Biochem Pharmacol; 1979 Apr; 28(7):1003-10. PubMed ID: 36086
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties.
    Weiland GA; Molinoff PB
    Life Sci; 1981 Jul; 29(4):313-30. PubMed ID: 6116136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.